Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LY3

Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab

Summary for 7LY3
Entry DOI10.2210/pdb7ly3/pdb
DescriptorSpike protein S1, SULFATE ION, S2M28 Fab Heavy Chain, ... (10 entities in total)
Functional Keywordsantibody, viral protein, structural genomics, seattle structural genomics center for infectious disease, ssgcid, viral protein-immune system complex, viral protein/immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
More
Total number of polymer chains6
Total formula weight175339.01
Authors
McCallum, M.,Veesler, D.,Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2021-03-05, release date: 2021-04-14, Last modification date: 2024-10-30)
Primary citationMcCallum, M.,De Marco, A.,Lempp, F.A.,Tortorici, M.A.,Pinto, D.,Walls, A.C.,Beltramello, M.,Chen, A.,Liu, Z.,Zatta, F.,Zepeda, S.,di Iulio, J.,Bowen, J.E.,Montiel-Ruiz, M.,Zhou, J.,Rosen, L.E.,Bianchi, S.,Guarino, B.,Fregni, C.S.,Abdelnabi, R.,Foo, S.C.,Rothlauf, P.W.,Bloyet, L.M.,Benigni, F.,Cameroni, E.,Neyts, J.,Riva, A.,Snell, G.,Telenti, A.,Whelan, S.P.J.,Virgin, H.W.,Corti, D.,Pizzuto, M.S.,Veesler, D.
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
Cell, 184:2332-, 2021
Cited by
PubMed Abstract: The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little is known about neutralizing Abs binding to epitopes outside the RBD and their contribution to protection. Here, we describe 41 human monoclonal Abs (mAbs) derived from memory B cells, which recognize the SARS-CoV-2 S N-terminal domain (NTD) and show that a subset of them neutralize SARS-CoV-2 ultrapotently. We define an antigenic map of the SARS-CoV-2 NTD and identify a supersite (designated site i) recognized by all known NTD-specific neutralizing mAbs. These mAbs inhibit cell-to-cell fusion, activate effector functions, and protect Syrian hamsters from SARS-CoV-2 challenge, albeit selecting escape mutants in some animals. Indeed, several SARS-CoV-2 variants, including the B.1.1.7, B.1.351, and P.1 lineages, harbor frequent mutations within the NTD supersite, suggesting ongoing selective pressure and the importance of NTD-specific neutralizing mAbs for protective immunity and vaccine design.
PubMed: 33761326
DOI: 10.1016/j.cell.2021.03.028
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon